Complement biomarkers in the antiphospholipid syndrome – Approaches to quantification and implications for clinical management
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement biomarkers in the antiphospholipid syndrome – Approaches to quantification and implications for clinical management
Authors
Keywords
-
Journal
CLINICAL IMMUNOLOGY
Volume -, Issue -, Pages 109828
Publisher
Elsevier BV
Online
2023-11-01
DOI
10.1016/j.clim.2023.109828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum and plasma levels of Ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients
- (2023) Ryoko Yamane et al. BMC Nephrology
- Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome
- (2022) Jason S. Knight et al. Seminars in Immunopathology
- Eculizumab for refractory thrombosis in antiphospholipid syndrome
- (2022) Habiba Hussain et al. Blood Advances
- Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”
- (2022) Brenda López-Benjume et al. AUTOIMMUNITY REVIEWS
- The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome registry”
- (2022) Ana Ponce et al. LUPUS
- Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d
- (2022) Savino Sciascia et al. Frontiers in Immunology
- How I diagnose and treat atypical hemolytic uremic syndrome
- (2022) Fadi Fakhouri et al. BLOOD
- How I treat thrombotic microangiopathy in the era of rapid genomics
- (2022) Alice Doreille et al. BLOOD
- Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus
- (2021) Yevgeniya Gartshteyn et al. CLINICAL IMMUNOLOGY
- Complement multiplex testing: Concept, promises and pitfalls
- (2021) Zoltán Prohászka et al. MOLECULAR IMMUNOLOGY
- A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab
- (2021) Anusha Chidharla et al. Journal of Blood Medicine
- More About Complement in the Antiphospholipid Syndrome
- (2020) Sjoerd Timmermans et al. BLOOD
- Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature
- (2020) Marta Skoczynska et al. LUPUS
- Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
- (2020) Elisabet Svenungsson et al. RHEUMATOLOGY
- Antiphospholipid syndrome: complement activation, complement gene mutations and therapeutic implications
- (2020) Shruti Chaturvedi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Successful outcome with eculizumab treatment in a patient with antiphospholipid syndrome presenting with an unusual thrombotic storm
- (2020) Jones T. Nauseef et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Absence of Distinct Immunohistochemical Distribution of Annexin A5, C3b, C4d, and C5b-9 in Placentas From Patients With Antiphospholipid Antibodies, Preeclampsia, and Systemic Lupus Erythematosus
- (2019) Cathleen E Matrai et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
- (2019) Ai-ris Yonekura Collier et al. HYPERTENSION IN PREGNANCY
- Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
- (2019) Paola Adele Lonati et al. Frontiers in Immunology
- Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
- (2019) Stephanie L. Savelli et al. Frontiers in Immunology
- Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome
- (2019) Cinzia Scambi et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Discordance between Free C5 and CH50 Complement Assays in Measuring Complement C5 Inhibition in Patients with aHUS Treated with Ravulizumab
- (2019) Spero Cataland et al. BLOOD
- Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS
- (2019) Shruti Chaturvedi et al. BLOOD
- Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies
- (2018) Mimi Y Kim et al. ANNALS OF THE RHEUMATIC DISEASES
- Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
- (2018) Ida Martinelli et al. HAEMATOLOGICA
- Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome
- (2018) Hiroyuki Nakamura et al. THROMBOSIS RESEARCH
- Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
- (2018) Ida Martinelli et al. HAEMATOLOGICA
- Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment
- (2018) Maria G. Tektonidou Frontiers in Immunology
- Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
- (2018) Francesco Tedesco et al. Frontiers in Immunology
- Diagnostic Utility of Complement Serology for Atypical Hemolytic Uremic Syndrome
- (2018) Meera Sridharan et al. MAYO CLINIC PROCEEDINGS
- Interpretation of Serological Complement Biomarkers in Disease
- (2018) Kristina N. Ekdahl et al. Frontiers in Immunology
- Thrombin activatable fibrinolysis inhibitor (TAFI) — A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS)
- (2017) Giorgia Grosso et al. THROMBOSIS RESEARCH
- A novel 2-stage approach that detects complement activation in patients with antiphospholipid antibody syndrome
- (2017) Jacob H. Rand et al. THROMBOSIS RESEARCH
- Cross Talk Pathways Between Coagulation and Inflammation
- (2016) Jonathan H. Foley et al. CIRCULATION RESEARCH
- Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndrome
- (2016) Kenji Oku et al. RHEUMATOLOGY
- Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
- (2016) Andreas Barratt-Due et al. RHEUMATOLOGY
- Neutrophil migration into the placenta: Good, bad or deadly?
- (2016) Stavros Giaglis et al. Cell Adhesion & Migration
- Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation Biomarkers
- (2015) Shangbin Yang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Thrombotic Microangiopathy in Systemic Lupus Erythematosus: Efficacy of Eculizumab
- (2015) Amr El-Husseini et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Soluble C5b-9 as a Biomarker for Complement Activation in Atypical Hemolytic Uremic Syndrome
- (2015) Fengxiao Bu et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery
- (2015) P. L. Meroni et al. BLOOD
- Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis
- (2015) A. Foltyn Zadura et al. JOURNAL OF RHEUMATOLOGY
- Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
- (2014) M. Noris et al. BLOOD
- A potential anti-coagulant role of complement factor H
- (2014) Janez Ferluga et al. MOLECULAR IMMUNOLOGY
- Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
- (2014) Guillaume Canaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System on Platelets in Systemic Lupus Erythematosus
- (2014) Christian Lood et al. PLoS One
- Generation of Multiple Fluid-Phase C3b:Plasma Protein Complexes during Complement Activation: Possible Implications in C3 Glomerulopathies
- (2013) M. Ramadass et al. JOURNAL OF IMMUNOLOGY
- Autoantibodies against complement components and functional consequences
- (2013) Marie-Agnès Dragon-Durey et al. MOLECULAR IMMUNOLOGY
- The Pathogenesis of the Antiphospholipid Syndrome
- (2013) Bill Giannakopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
- (2013) Lucy V. Holmes et al. PLoS One
- Relation of Platelet C4d with All-Cause Mortality and Ischemic Stroke in Patients with Systemic Lupus Erythematosus
- (2013) Amy H Kao et al. Translational Stroke Research
- Preeclampsia Is Characterized by Placental Complement Dysregulation
- (2012) Aletta Buurma et al. HYPERTENSION
- Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus – a possible link to venous thrombosis?
- (2012) C Lood et al. LUPUS
- C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies
- (2012) AL Carrera-Marín et al. LUPUS
- Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant
- (2012) Savino Sciascia et al. THROMBOSIS AND HAEMOSTASIS
- Eculizumab in Acute Recurrence of Thrombotic Microangiopathy After Renal Transplantation
- (2011) K. Hadaya et al. AMERICAN JOURNAL OF TRANSPLANTATION
- 2-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator
- (2011) K. Gropp et al. BLOOD
- Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss
- (2011) Danielle Cohen et al. JOURNAL OF PATHOLOGY
- Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma
- (2011) R. Norda et al. VOX SANGUINIS
- Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome
- (2010) E. Ortona et al. BLOOD
- Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome
- (2010) Tara K. Maga et al. HUMAN MUTATION
- Association of IgA Anti-ss2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus
- (2010) T. MEHRANI et al. JOURNAL OF RHEUMATOLOGY
- Eculizumab and Renal Transplantation in a Patient with CAPS
- (2010) Bonnie E. Lonze et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is there an association between complement activation and antiphospholipid antibody-related thrombosis?
- (2010) Marc F. Hoylaerts et al. THROMBOSIS AND HAEMOSTASIS
- Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
- (2009) V. PENGO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies
- (2009) EIB Peerschke et al. LUPUS
- Complement activation in patients with primary antiphospholipid syndrome
- (2008) K Oku et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now